2. Academic Validation
  3. Development of a covalent inhibitor of gut bacterial bile salt hydrolases

Development of a covalent inhibitor of gut bacterial bile salt hydrolases

  • Nat Chem Biol. 2020 Mar;16(3):318-326. doi: 10.1038/s41589-020-0467-3.
Arijit A Adhikari 1,  Tom C M Seegar 1,  Scott B Ficarro 2 3,  Megan D McCurry 1,  Deepti Ramachandran 4,  Lina Yao 1,  Snehal N Chaudhari 1,  Sula Ndousse-Fetter 1,  Alexander S Banks 4,  Jarrod A Marto 2 3,  Stephen C Blacklow 1,  A Sloan Devlin 5
Affiliations

Affiliations

  • 1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
  • 2 Department of Cancer Biology, Department of Oncologic Pathology, Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, MA, USA.
  • 3 Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • 4 Division of Endocrinology, Metabolism, and Diabetes, Beth Israel Deaconness Medical Center, Boston, MA, USA.
  • 5 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. sloan_devlin@hms.harvard.edu.
PMID: 32042200 DOI: 10.1038/s41589-020-0467-3
Abstract

Bile salt hydrolase (BSH) Enzymes are widely expressed by human gut bacteria and catalyze the gateway reaction leading to secondary bile acid formation. Bile acids regulate key metabolic and immune processes by binding to host receptors. There is an unmet need for a potent tool to inhibit BSHs across all gut bacteria to study the effects of bile acids on host physiology. Here, we report the development of a covalent pan-inhibitor of gut Bacterial BSHs. From a rationally designed candidate library, we identified a lead compound bearing an alpha-fluoromethyl ketone warhead that modifies BSH at the catalytic cysteine residue. This inhibitor abolished BSH activity in conventional mouse feces. Mice gavaged with a single dose of this compound displayed decreased BSH activity and decreased deconjugated bile acid levels in feces. Our studies demonstrate the potential of a covalent BSH inhibitor to modulate bile acid composition in vivo.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z